Loading
₹202.67
+2.15+1.07%today
Market closed · 7 Oct, 3:30 pm
+3.64%over 1 year
Today's range
₹199.99₹205.10
52-week range
₹132.30₹231.93
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 8,759 | −326 | -3.7% | -2.46 |
| FY25 | 9,061 | 91 | 1.0% | 0.69 |
| FY24 | 8,106 | 18 | 0.2% | 0.14 |
| FY23 | 7,032 | −186 | -2.7% | -1.54 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 34.80% | 34.86% | 34.86% | 34.86% |
| FIIs | 12.52% | 30.18% | 29.66% | 30.27% |
| DIIs | 14.57% | 15.61% | 15.69% | 14.89% |
| of which mutual funds | 13.18% | 14.12% | 14.03% | 13.11% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 37.63% | 19.01% | 19.35% | 19.47% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Sai Life Sciences Ltd.SAILIFE | 1,558.70 | +0.04% | 33,110 |
| Dr. Lal Path Labs Ltd.LALPATHLAB | 1,938.00 | −1.33% | 32,529 |
| Krishna Institute of Medical Sciences Ltd.KIMS | 693.00 | −0.06% | 29,106 |
| Neuland Laboratories Ltd.NEULANDLAB | 21,610.00 | −1.35% | 27,725 |
| Piramal Pharma Ltd.PPLPHARMA · this stock | 202.67 | +1.07% | 26,982 |
| Rubicon Research Ltd.RUBICON | 1,570.00 | −1.68% | 25,989 |
| Acutaas Chemicals Ltd.ACUTAAS | 3,168.60 | +0.38% | 25,942 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.